HIF-1α, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors
- 1 December 2002
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 54 (5), 1537-1549
- https://doi.org/10.1016/s0360-3016(02)03935-4
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002
- Role of AP-1 and HIF-1 Transcription Factors in TGF-β Activation of VEGF ExpressionGrowth Factors, 2001
- Regulation of Mammalian O2Homeostasis by Hypoxia-Inducible Factor 1Annual Review of Cell and Developmental Biology, 1999
- Hypoxia-inducible Factor 1α (HIF-1α) Protein Is Rapidly Degraded by the Ubiquitin-Proteasome System under Normoxic ConditionsJournal of Biological Chemistry, 1997
- Hypoxia Response Elements in the Aldolase A, Enolase 1, and Lactate Dehydrogenase A Gene Promoters Contain Essential Binding Sites for Hypoxia-inducible Factor 1Journal of Biological Chemistry, 1996
- Dimerization, DNA Binding, and Transactivation Properties of Hypoxia-inducible Factor 1Journal of Biological Chemistry, 1996
- Calibration of misonidazole labeling by simultaneous measurement of oxygen tension and labeling density in multicellular spheroidsInternational Journal of Cancer, 1995
- A morphometric study of the vascularity of oral squamous cell carcinomas and its relation to outcome of radiation therapyEuropean Journal of Cancer and Clinical Oncology, 1989
- Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenationThe British Journal of Radiology, 1979
- Intercapillary Distance, Oxygen Tension and Local Recurrence in Cervix CancerScandinavian Journal of Clinical and Laboratory Investigation, 1968